Home
About
Team
Pipeline
Patient Information
Partnerships
News
Contact
More
Orpha Labs AG Initiates Compassionate Use Program for ORL-101 in Leukocyte Adhesion Deficiency Type II (LAD-II)
First Patient to Receive ORL-101 in Israel This Week
Feb 08, 2021, 02:00 ET